[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"status-days":3,"stock-4162":32,"stock-themes-4162":133},[4,18],{"date":5,"taiex_close":6,"taiex_chg":7,"taiex_chg_pct":8,"advancers":9,"decliners":10,"unchanged":11,"stocks":12,"turnover_sum":13,"margin_balance":14,"margin_chg":15,"short_balance":16,"short_chg":17},"2026-10-12",49301.96,-11.480000000003201,-0.00023279657634922568,868,916,158,1971,1044705369816,9174215,2895,175930,1165,{"date":19,"taiex_close":20,"taiex_chg":21,"taiex_chg_pct":22,"advancers":23,"decliners":24,"unchanged":25,"stocks":26,"turnover_sum":27,"margin_balance":28,"margin_chg":29,"short_balance":30,"short_chg":31},"2026-10-13",48341.31,-960.6500000000015,-0.019485026558781926,444,1337,161,1975,1306098703553,9070158,-104057,168869,-7061,{"profile":33,"snapshot":50,"data_version":132},{"code":34,"name":35,"full_name":36,"market":37,"kind":38,"industry":39,"listed_date":40,"chairman":41,"president":42,"capital":43,"shares":44,"founded_date":45,"website":46,"address":47,"english_name":48,"dividend_frequency":49},"4162","智擎","智擎生技製藥股份有限公司","otc","stock","生技醫療業","2012-09-18","許璋瑤","王宏仁",1436776400,143677640,"2002-08-12","https:\u002F\u002Fwww.pharmaengine.com","台北市民生東路3段10號11樓","PEI","每年",{"code":34,"name":35,"market":37,"kind":38,"industry":39,"close":51,"chg":52,"chg_pct":53,"ret_5d":54,"ret_20d":55,"volume":56,"turnover":57,"mcap":58,"signals":59,"as_of":19,"ref_price":62,"ret_60d":63,"ret_ytd":64,"open":65,"high":66,"low":67,"pe":68,"pb":69,"dy":70,"foreign_net_1d":71,"foreign_net_5d":72,"trust_net_1d":73,"trust_net_5d":73,"dealer_net_1d":74,"dealer_net_5d":75,"foreign_holding_pct":76,"margin_balance":77,"margin_chg":78,"short_balance":73,"short_chg":73,"large_holder_pct":79,"large_holder_chg_1w":80,"large_holder_chg_4w":81,"holders_date":82,"high_52w":83,"low_52w":84,"rev_period":85,"rev_yoy":86,"eps_period":87,"eps":88,"spark":89},56.5,-0.7999999999999972,-0.013961605584642212,0.027272727272727337,0.031021897810219023,249227,14152607,8230784400,[60,61],"rev_yoy","eps_yoy",57.3,-0.12078012549365535,-0.1707358001815158,57.4,57.5,56.3,15.27,1.65,3.54,-46000,-134559,0,15720,15786,11.69,2133,-7,38.08,-0.6400000000000006,-0.8999999999999986,"2026-10-09",74.4,53,"2026-09",13.07,"2026-Q2",0.9200796828064163,[90,91,92,93,94,95,96,91,97,98,99,100,101,90,102,90,103,90,104,105,106,107,108,109,110,111,112,108,113,114,111,108,115,116,117,117,118,119,120,121,122,123,121,124,120,125,120,67,126,127,128,125,129,128,130,130,120,131,62,51],63.7,64.3,68,68.4,66.8,65.9,65.8,63.5,61.5,61.4,62,63,63.2,64.7,62.9,63.6,62.1,59.1,59,58.2,59.3,60,59.2,60.1,60.5,58.4,57.7,57.8,57,56.4,55.8,54.8,54,54.1,54.6,55.6,56.2,55.5,55.4,55.3,55,57.2,"20261013-fcba10",[134],{"theme":135,"segment":142,"tier":143,"role":144,"relevance":145,"note":146,"peers":147,"upstream":217,"downstream":224},{"id":130,"slug":136,"name":137,"category":138,"ret_1d":141},"new-drugs","新藥研發",{"slug":139,"name":140},"biotech","生技醫療",-0.025792561311777984,"新藥開發與臨床","upstream","niche","high","新藥開發與授權",[148,162,174,185,196,208],{"code":149,"name":150,"role":151,"relevance":145,"note":152,"industry":39,"close":17,"chg_pct":153,"ret_5d":154,"ret_20d":155,"mcap":156,"turnover":157,"signals":158},"6446","藥華藥","leader","血液疾病新藥，已有上市產品",-0.016877637130801593,-0.021008403361344352,-0.11742424242424243,492134794500,1315551970,[60,159,61,160,161],"rev_yoy_3m","trust_buy_5d","holders_up",{"code":163,"name":164,"role":144,"relevance":145,"note":165,"industry":39,"close":166,"chg_pct":167,"ret_5d":168,"ret_20d":169,"mcap":170,"turnover":171,"signals":172},"4743","合一","傷口與皮膚新藥",47.55,-0.03451776649746208,0.009554140127388422,0.04390779363336983,22849367925,83204957,[61,173,161],"foreign_buy_5d",{"code":175,"name":176,"role":144,"relevance":145,"note":177,"industry":39,"close":178,"chg_pct":179,"ret_5d":180,"ret_20d":181,"mcap":182,"turnover":183,"signals":184},"4147","中裕","愛滋病抗體藥，已有上市產品",58.3,-0.036363636363636376,-0.028333333333333433,-0.0535714285714286,15927699919.999998,72544406,[],{"code":186,"name":187,"role":144,"relevance":188,"note":189,"industry":39,"close":122,"chg_pct":190,"ret_5d":191,"ret_20d":192,"mcap":193,"turnover":194,"signals":195},"1760","寶齡富錦","mid","腎臟病用藥與保健品",-0.021739130434782594,0.0018552875695734272,-0.018181818181818077,4629906702,4998637,[60,61,173],{"code":197,"name":198,"role":199,"relevance":145,"note":200,"industry":39,"close":201,"chg_pct":202,"ret_5d":203,"ret_20d":204,"mcap":205,"turnover":206,"signals":207},"6550","北極星藥業-KY","challenger","癌症新藥開發",15.9,-0.027522935779816682,-0.01851851851851838,-0.19039113027409926,14227203930.000002,8240813,[61,173,161],{"code":209,"name":210,"role":199,"relevance":145,"note":200,"industry":39,"close":120,"chg_pct":211,"ret_5d":212,"ret_20d":213,"mcap":214,"turnover":215,"signals":216},"4174","浩鼎",-0.029565217391304355,0.20779220779220764,1.1338432122370938,7342146534.599999,43742268,[61],[218],{"id":219,"slug":220,"name":221,"category":222,"ret_1d":223},56,"cdmo-generics","CDMO 與學名藥",{"slug":139,"name":140},-0.010249642314885767,[]]